Ginkgetin induces apoptosis in 786-O cell line <i>via</i> suppression of JAK2-STAT3 pathway.

Abstract

Our results indicate Ginkgetin possesses obvious inhibitory effects on the proliferation of 786-O, and this effect is probably due to its inhibition of JAK2/STAT3 pathway. Our findings imply Ginkgetin is a potential therapeutic medicine for RCC.